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Changes in the epidemiology of Haemophilus inﬂuenzae
invasive disease, in Portugal, after the introduction of the
Hib vaccine
M.P. Bajanca-Lavado ∗, C. Betencourt
National Institute of Health Dr. Ricardo Jorge, Lisbon, Por-
tugal
Background: Haemophilus inﬂuenzae (Hi) is responsi-
ble for a number of human diseases ranging from chronic
infections to meningitis. Most of the isolates are non-
encapsulated (NC), although it is known until now six
serotypes (a-f). Hi serotype b (Hib) vaccine was adopted
in Portugal since 1994 and obligated since the year 2000
to children less than ﬁve years old. Our aim is to analyse
the serotypes of Hi invasive strains in parallel with possible
changes in antimicrobial susceptibility, before and after the
introduction of vaccine.
Methods: We collected 104 invasive Hi isolates (50 CSF,
52 blood cultures and 2 pleural ﬂuids) from 1989 to 2000,
and 111 (22 CSF, 81 blood cultures and 8 pleural ﬂuids) from
2001 to 2008, from several Hospital Laboratories in Por-
tugal. Fifty two strains (50%) were isolated from children
(<18 years old) in the ﬁrst period and 34 (32.7%) after the
vaccination period. Identiﬁcation of Hi was conﬁrmed by
standard procedures. Susceptibility testing was performed
by a microdilution assay, according to the CLSI guidelines.
$-lactamase production was determined with nitroceﬁn.
Serotyping was performed by PCR.
Results: In relation to ampicillin resistance, $-lactamase
producing was detected in 28.8% of the strains in the period
1989—2000, and 12.6% between 2001-2008. Five strains
(5.2%), all isolated in the pos vaccine period, had MIC values
to ampicillin and clavulanic acid of 2mg/L, which indicates
BLNAR possible. In relation to serotype characterization, in
the pre-vaccine period, 68.3% of the strains were Hib and
31.7% were NC; after the introduction of the vaccine, 12.6%
were Hib, 79,3% NC, and 8.1% non-b-type (2.7% a and 5.4%
f).
Conclusion: Considering the two periods 1989—2000 and
2001—2008 we observe a rise in NC strains and a decline
in serotype b, in invasive disease in Portugal. Non-b-type
strains were characterized only after the introduction of
the vaccine. In this way, we document changes in invasive
infections following the introduction of the vaccine in Portu-
gal, with an emergence of NC and an increase of serotypes
other than b. We also expect a new rule in the virulence
mechanisms of these strains.
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Analysis of clinical outcome in patients with multidrug-
resistant Acinetobacter baumannii bacteremia
M.W. Kang ∗, Y.J. Kim, K.-W. Hong, S.I. Kim, Y.R. Kim, Y.-J.
ParkThe catholic University of Korea, Seoul, Korea, Republic of
Background: Multidrug-resistant Acinetobacter bauman-
nii (MDRAB) has been increasing reported worldwide, and
d
t
t
its e219
he therapeutic options are limited. The aim of this study
as to investigate clinical characteristic, risk factors for
ortality and outcome among patients with MDRAB bac-
eremia.
Methods: A retrospective study was performed at a ter-
iary care hospital in Korea from January 2005 to July 2009.
nly ﬁrst bacteremic episode from one patient was included
n the study. Antibiotic therapy was considered to be appro-
riate if the isolated strain was sensitive, in vitro, to initial
ntibiotic, which were administered within 48 hours after
lood culture sample obtained. Multidrug-resistant Acineto-
acter baumannii (MDRAB) was deﬁned as resistance to all
ommercially available antibiotics except colistin.
Results: Seventy-seven patients (40 male, 37 female)
ith Acinetobacter baumannii bacteremia were included.
he presumed sources of bacteremia that caused bac-
eremia were lung (n = 24,31.2%), catheter (n = 21, 27.3%),
ntraabdomen (n = 13, 17%), postoperative wound (n = 6,
.8%), urinary tract (n = 5,6.5%), and unknown (n = 8, 10.4%).
orty—three patients(55.8%) were infected with MDRAB. The
verall 30-day mortality in patients with Acinetobacter bau-
annii bacteremia was 33.7%(26/77), and was higher in
DRAB patients than non-MDRAB (62.5% vs 20.8%, p < 0.05).
ccording to univariate analysis, diabetes mellitus, central
enous catheter, mechanical ventilation, hospital day until
acteremia, inappropriate antimicrobial therapy, resistance
o imipenem and resistance to multidrug except colistin
ere associated with 30-day mortality (p < 0.05). Multivari-
te analysis using logistic regression model showed that
igniﬁcant risk factors for 30-day mortality were mechan-
cal ventilator (OR = 5.6, 95% CI 1.24-.24.83, p = 0.02), and
esistance to multidrug (OR = 40.77, 95% CI 3.95-420.85,
= 0.001).
Conclusion: Patients with MDRAB bacteremia showed
igher mortality rate than non-MDR bacteremia, although
nderlying status play an important role in clinical outcome.
he efforts to minimize the emergence of antimicrobial
esistance should be important.
oi:10.1016/j.ijid.2010.02.1974
2.017
linical proﬁle and antimicrobial resistance pattern of
nteroaggregative E.coli isolated from patients with diar-
hoea, using a multiplex PCR assay in a tertiary care
ospital in North India
. Pahil ∗, N. Taneja, G. Singh, M. Sharma
Post Graduate Institute of Medical Education and Research,
handigarh, India
Background: Enteroaggregative Escherichia coli (EAEC)
s an increasingly recognized enteric pathogen which
an cause both acute and persistent diarrhoea in chil-
ren,traveller’s diarrhoea and diarrhoea in immunocompro-
ised patients. The identiﬁcation of EAEC by conventional
echniques is technically demanding and time consuming.
he genetic and phenotypic heterogeneity also makes the
iagnosis of EAEC difﬁcult. Therefore a single assay mul-
iplex polymerase chain reaction (PCR) can be useful for
he identiﬁcation of enteroaggregative Escherichia coli. To
dentify both typical and atypical EAEC with a high sensitiv-
